{"transactions":[{"id":794641,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, U.S. Commercial"}}],"security":"Ordinary Shares","published_at":"2026-05-04T20:00:53.000Z","date":"2026-04-30","kind":"sale","planned":false,"acquired":false,"shares":21258,"price":35.31,"value":750619.98,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.28 to $35.33, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":63647,"source":{"system":"sec-edgar","filing":"0001193125-26-203920","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526203920/ownership.xml","form_type":"4"}},{"id":854922,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, U.S. Commercial"}}],"security":"Restricted Share Units","published_at":"2026-03-09T20:16:34.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":false,"shares":17819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 17,819 vested on March 5, 2026, 17,819 vesting on each of March 5, 2027 and March 5, 2028, and 17,821 vesting on March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 17,819 vested on March 5, 2026, 17,819 vesting on each of March 5, 2027 and March 5, 2028, and 17,821 vesting on March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":53459,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17819},"source":{"system":"sec-edgar","filing":"0001193125-26-098541","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098541/ownership.xml","form_type":"4"}},{"id":854921,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, U.S. Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:16:34.000Z","date":"2026-03-05","kind":"sale","planned":true,"acquired":false,"shares":7924,"price":31.6684,"value":250940.4016,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.26 to $32.34, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":84905,"source":{"system":"sec-edgar","filing":"0001193125-26-098541","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098541/ownership.xml","form_type":"4"}},{"id":854920,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, U.S. Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:16:34.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":true,"shares":17819,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":92829,"source":{"system":"sec-edgar","filing":"0001193125-26-098541","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098541/ownership.xml","form_type":"4"}},{"id":857140,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, U.S. Commercial"}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:05:57.000Z","date":"2026-03-04","kind":"grant","planned":true,"acquired":true,"shares":50643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 4, 2026, with 12,660 vesting on each of March 4, 2027, March 4, 2028 and March 4, 2029, and 12,663 vesting on March 4, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 4, 2026, with 12,660 vesting on each of March 4, 2027, March 4, 2028 and March 4, 2029, and 12,663 vesting on March 4, 2030."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":50643,"derivative":{"underlying":"Ordinary Shares","underlying_shares":50643},"source":{"system":"sec-edgar","filing":"0001193125-26-096498","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096498/ownership.xml","form_type":"4"}},{"id":857139,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, U.S. Commercial"}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:05:57.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":false,"shares":20461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 4, 2024, with 20,461 vested on each of March 4, 2025 and March 4, 2026, 20,461 vesting on March 4, 2027, and 20,462 vesting on March 4, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 4, 2024, with 20,461 vested on each of March 4, 2025 and March 4, 2026, 20,461 vesting on March 4, 2027, and 20,462 vesting on March 4, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":40923,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20461},"source":{"system":"sec-edgar","filing":"0001193125-26-096498","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096498/ownership.xml","form_type":"4"}},{"id":857138,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, U.S. Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:05:57.000Z","date":"2026-03-04","kind":"sale","planned":true,"acquired":false,"shares":9098,"price":32.4645,"value":295362.021,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.095 to $33.30, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":75010,"source":{"system":"sec-edgar","filing":"0001193125-26-096498","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096498/ownership.xml","form_type":"4"}},{"id":857137,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, U.S. Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:05:57.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":true,"shares":20461,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":84108,"source":{"system":"sec-edgar","filing":"0001193125-26-096498","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096498/ownership.xml","form_type":"4"}},{"id":990683,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Restricted Share Units","published_at":"2025-11-24T21:03:10.000Z","date":"2025-11-20","kind":"exercise","planned":true,"acquired":false,"shares":63492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on November 20, 2023, with 63,492 vested on each of November 20, 2024 and November 20, 2025, and 63,492 vesting on each of November 20, 2026 and November 20, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on November 20, 2023, with 63,492 vested on each of November 20, 2024 and November 20, 2025, and 63,492 vesting on each of November 20, 2026 and November 20, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":126984,"derivative":{"underlying":"Ordinary Shares","underlying_shares":63492},"source":{"system":"sec-edgar","filing":"0001193125-25-293655","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312525293655/ownership.xml","form_type":"4"}},{"id":990682,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Ordinary Shares","published_at":"2025-11-24T21:03:10.000Z","date":"2025-11-20","kind":"sale","planned":true,"acquired":false,"shares":28229,"price":24.7803,"value":699523.0887,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."}],"balance_after":63647,"source":{"system":"sec-edgar","filing":"0001193125-25-293655","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312525293655/ownership.xml","form_type":"4"}},{"id":990681,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Ordinary Shares","published_at":"2025-11-24T21:03:10.000Z","date":"2025-11-20","kind":"exercise","planned":true,"acquired":true,"shares":63492,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":91876,"source":{"system":"sec-edgar","filing":"0001193125-25-293655","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312525293655/ownership.xml","form_type":"4"}},{"id":996996,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Ordinary Shares","published_at":"2025-11-18T21:01:21.000Z","date":"2025-11-14","kind":"sale","planned":false,"acquired":false,"shares":30000,"price":25.1107,"value":753321.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":28384,"source":{"system":"sec-edgar","filing":"0001193125-25-286134","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312525286134/ownership.xml","form_type":"4"}},{"id":1218518,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Restricted Share Units","published_at":"2025-03-07T21:25:43.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":71278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on March 5, 2025, with 17,819 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 17,821 vesting on March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on March 5, 2025, with 17,819 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 17,821 vesting on March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":71278,"derivative":{"underlying":"Ordinary Shares","underlying_shares":71278},"source":{"system":"sec-edgar","filing":"0000950170-25-035537","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025035537/ownership.xml","form_type":"4"}},{"id":1220829,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Restricted Share Units","published_at":"2025-03-06T21:19:28.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":false,"shares":20461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 4, 2024, with 20,461 vested on March 4, 2025, 20,461 vesting on each of March 4, 2026 and March 4, 2027, and 20,462 vesting on March 4, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 4, 2024, with 20,461 vested on March 4, 2025, 20,461 vesting on each of March 4, 2026 and March 4, 2027, and 20,462 vesting on March 4, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":61384,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20461},"source":{"system":"sec-edgar","filing":"0000950170-25-034687","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034687/ownership.xml","form_type":"4"}},{"id":1220828,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:19:28.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":2147,"price":15.9132,"value":34165.6404,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2024."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.68 to $16.13, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":58384,"source":{"system":"sec-edgar","filing":"0000950170-25-034687","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034687/ownership.xml","form_type":"4"}},{"id":1220827,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:19:28.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":4034,"price":15.7346,"value":63473.3764,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2024."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.28 to $16.015, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":60531,"source":{"system":"sec-edgar","filing":"0000950170-25-034687","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034687/ownership.xml","form_type":"4"}},{"id":1220826,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:19:28.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":true,"shares":20461,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":64565,"source":{"system":"sec-edgar","filing":"0000950170-25-034687","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034687/ownership.xml","form_type":"4"}},{"id":1356461,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Restricted Share Units","published_at":"2024-11-21T21:04:21.000Z","date":"2024-11-20","kind":"exercise","planned":true,"acquired":false,"shares":63492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on November 20, 2023, with 63,492 vested on November 20, 2024, and 63,492 vesting on each of November 20, 2025, November\n20, 2026 and November 20, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on November 20, 2023, with 63,492 vested on November 20, 2024, and 63,492 vesting on each of November 20, 2025, November\n20, 2026 and November 20, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":190476,"derivative":{"underlying":"Ordinary Shares","underlying_shares":63492},"source":{"system":"sec-edgar","filing":"0000950170-24-129709","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024129709/ownership.xml","form_type":"4"}},{"id":1356460,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Ordinary Shares","published_at":"2024-11-21T21:04:21.000Z","date":"2024-11-20","kind":"sale","planned":true,"acquired":false,"shares":19388,"price":16.8705,"value":327085.254,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2024."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."}],"balance_after":44104,"source":{"system":"sec-edgar","filing":"0000950170-24-129709","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024129709/ownership.xml","form_type":"4"}},{"id":1356459,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Ordinary Shares","published_at":"2024-11-21T21:04:21.000Z","date":"2024-11-20","kind":"exercise","planned":true,"acquired":true,"shares":63492,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":63492,"source":{"system":"sec-edgar","filing":"0000950170-24-129709","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024129709/ownership.xml","form_type":"4"}},{"id":1600203,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Restricted Share Units","published_at":"2024-03-05T21:35:36.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":81845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on March 4, 2024, with 20,461 vesting on each of March 4, 2025, March 4, 2026 and March 4, 2027, and 20,462 vesting on March 4, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on March 4, 2024, with 20,461 vesting on each of March 4, 2025, March 4, 2026 and March 4, 2027, and 20,462 vesting on March 4, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":81845,"derivative":{"underlying":"Ordinary Shares","underlying_shares":81845},"source":{"system":"sec-edgar","filing":"0000950170-24-026063","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024026063/ownership.xml","form_type":"4"}},{"id":1731917,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Restricted Share Units","published_at":"2023-11-22T12:18:44.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":253968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on November 20, 2023, with 63,492 vesting on each of November 20, 2024, November 20, 2025, November 20, 2026 and November 20, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on November 20, 2023, with 63,492 vesting on each of November 20, 2024, November 20, 2025, November 20, 2026 and November 20, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":253968,"derivative":{"underlying":"Ordinary Shares","underlying_shares":253968},"source":{"system":"sec-edgar","filing":"0001209191-23-056412","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123056412/doc4.xml","form_type":"4"}}]}